Viking Therapeutics, Inc. is rated a Sell, has no revenue, and has no product available to the public at this time. Learn ...

If you look beyond the upside potential, there's still plenty of risk to navigate past.

Viking stock is known for soaring after positive news.

Viking's strong obesity drug data continues fueling acquisition speculation.

Demand for weight loss drugs may fuel growth for more than one player.

Shares of Viking Therapeutics fell 40% on Tuesday after the company released midstage trial data on its obesity pill that disappointed investors. While the weight loss caused by Viking's pill was ...

If you're looking to capitalize on the rapidly growing market for weight loss drugs, you can do so in different ways. One strategy is to invest in companies like Eli Lilly or Novo Nordisk that already ...

Detailed price information for Indivior Pharmaceuticals Inc (INDV-Q) from The Globe and Mail including charting and trades.

Viking Therapeutics (VKTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.